GBT Announces New Employment Inducement Grants
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St set for higher open but weekly losses loom
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Global Blood Therapeutics (GBT) PT Lowered to $74 at Oppenheimer
May 8, 2018 7:51 AM EDTOppenheimer lowered its price target on Global Blood Therapeutics (NASDAQ: GBT) to $74.00 (from $79.00) while maintaining a Outperform rating.
Analyst Mark Breidenbach commented, "Monday, Global Blood announced 1Q18 financial results and we discussed upcoming milestones with management. Results from the first 150... More
